ReviewInternational journal of molecular sciences2020

Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System.

Kim M A De Kleijn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.